atomoxetine hydrochloride has been researched along with Hypoxia-Ischemia, Brain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, T; Ichinose, M; Imada, S; Iriyama, T; Kamei, Y; Seyama, T; Toshimitsu, M | 1 |
1 other study(ies) available for atomoxetine hydrochloride and Hypoxia-Ischemia, Brain
Article | Year |
---|---|
Atomoxetine, a selective norepinephrine reuptake inhibitor, improves short-term histological outcomes after hypoxic-ischemic brain injury in the neonatal male rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Atomoxetine Hydrochloride; Brain; Cell Death; Cyclic AMP Response Element-Binding Protein; Functional Laterality; Hypoxia-Ischemia, Brain; Interleukin-1beta; Male; Microdialysis; Microglia; Neurons; Nitric Oxide Synthase Type II; Primary Cell Culture; Rats | 2018 |